What is Odomzo used for?

1 INDICATIONS AND USAGE ODOMZO (sonidegib) is indicated for the treatment of adult patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. ODOMZO is a hedgehog pathway inhibitor indicated for the treatment of adult patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery

How does Odomzo work?

11 DESCRIPTION Sonidegib is a Hh pathway inhibitor.

What pharmaceutical form is Odomzo available in?

Odomzo: Kapsułki twarde 200 mg (doustna)

Is Odomzo OTC or prescription only?

Odomzo requires a doctor's prescription.

What are the side effects of Odomzo?

6 ADVERSE REACTIONS The following clinically significant adverse reactions are described elsewhere in the labeling: Musculoskeletal Adverse Reactions [see Warnings and Precautions (5.2) ] . The most common adverse reactions occurring in ≥10% of patients are muscle spasms, alopecia, dysgeusia, fatigue, nausea, musculoskeletal pain, diarrhea, decreased weight, decreased appetite, myalgia, abdominal pain, headache, pain, vomiting, and pruritus. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact

Who should NOT take Odomzo?

4 CONTRAINDICATIONS None. None. ( 4 )

Does Odomzo interact with other medications?

7 DRUG INTERACTIONS CYP3A inhibitors: Avoid strong CYP3A inhibitors. Avoid long-term (greater than 14 days) use of moderate CYP3A inhibitors. ( 7.1 ) CYP3A inducers: Avoid strong and moderate CYP3A inducers. ( 7.1 ) 7.1 Effects of Other Drugs on ODOMZO Strong and Moderate CYP3A Inhibitors Avoid concomitant administration of ODOMZO with strong CYP3A inhibitors [see Clinical Pharmacology (12.3) ]. Avoid concomitant administration of ODOMZO with moderate CYP3A inhibitors. If a moderate CYP3A inhibi

Can Odomzo be used during pregnancy?

8 USE IN SPECIFIC POPULATIONS Lactation: Advise not to breastfeed. ( 8.2 ) 8.1 Pregnancy Risk Summary Based on its mechanism of action and data from animal reproduction studies, ODOMZO can cause fetal harm when administered to a pregnant woman [see Clinical Pharmacology (12.1) ]. There are no available data on the use of ODOMZO in pregnant women. In animal reproduction studies, oral administration of sonidegib during organogenesis at doses below the recommended human dose of 200 mg resulted in e

Who manufactures Odomzo?

Sun Pharmaceutical Industries Europe B.V. (Holandia)

What ATC class does Odomzo belong to?

Odomzo: ATC L01XJ02. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

Odomzo

200 mg, Kapsułki twarde

INN: Sonidegibum

Data updated: 2026-04-13

Available in:

🇨🇿🇩🇪🇬🇧🇵🇱🇵🇹🇸🇰

Form

Kapsułki twarde

Dosage

200 mg

Route

doustna

Storage

—

About This Product

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.